Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urotoxic metabolites of oxazaphosphorines, primarily acrolein, are toxic byproducts formed during the metabolism of cyclophosphamide and ifosfamide. These metabolites cause direct damage to bladder mucosa, leading to inflammation and bleeding (hemorrhagic cystitis). Mesna is used to neutralize acrolein in the urine, preventing urotoxicity.
Direct chemical injury to bladder mucosa via covalent binding to cellular macromolecules.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urotoxic Metabolites of Oxazaphosphorines.